In this session we will hear from emerging women leaders in prostate cancer including highlights in prostate cancer research from 2021, treatment of castrate-resistant prostate cancer and genomics for early detection of prostate cancer.

This session is sponsored by AstraZeneca. Chat to the team in the catering breaks by clicking here

Join our Nursing & Allied Health Conveners - David Gray, Rachel Heerey and Evie Mertens for Day 2 of the Conference.

This innovative session provides an introduction to prostate cancer by following a patient from the GP's office all the way through to palliation. Experts across the care continuum will cover everything from PSA to biopsy, histopathology, available treatments, side effects and supportive care. A brilliant initiation into prostate cancer and the knowledge required to care for this patient population.

 This session is sponsored by Cipla. Chat to the team in the catering breaks by clicking here

Thank you to IPSEN for their support of this poster session. Visit the IPSEN sponsor page by clicking here

This morning tea break is sponsored by Genesis Care. Chat to the team by clicking here

What are the most important papers pertaining to prostate cancer in 2021? In this session you will hear from specialists across all disciplines involved in prostate cancer patient care. Find out what the latest evidence is and how it can better inform your clinical practice.
 
This session is sponsored by AstraZeneca. Chat to the team in the catering breaks by clicking here

Whilst most of the change in prostate cancer management has been in the metastatic setting, even the treatment of localized disease is evolving. Local and international speakers will cover wide ranging topics, including PSMA PET imaging in the diagnosis of local disease, optimizing the delivery of radiation, the role of pelvic lymphadenectomy in the PSMA PET era and whether or not there is still a role for adjuvant radiation.

This session is sponsored by Astellas. Chat to the team in the catering breaks by clicking here

Thank you to IPSEN for their support of this poster session. Visit the IPSEN sponsor page by clicking here

This lunch break is sponsored by Karl Storz. Chat to the team by clicking here

What happens after prostate cancer diagnosis and treatment? Learn from the top researchers and clinicians the essential tools for prostate cancer survivorship, models of psychosocial care, how and when to measure cost effectiveness, how research can translate to clinical practice and exercise prescription in action. This session examines who our most disadvantaged patients are and provides valuable insights into how we can best support them throughout treatment and follow up.

This session is sponsored by Astellas. Chat to the team in the catering breaks by clicking here

This session is sponsored by Mundipharma. Chat to the team in the catering breaks by clicking here

Thank you to IPSEN for their support of this poster session. Visit the IPSEN sponsor page by clicking here

This afternoon tea break is sponsored by Device Technologies. Chat to the team by clicking here

This comprehensive session likely covers everything you have ever wanted to know about radiotherapy. What it is, how it is given, what the short- and long-term complications are and how we can optimally prepare our patients for radiotherapy. A valuable session for anyone involved in prostate cancer patient survivorship.

This session is sponsored by Janssen. Chat to the team in the catering breaks by clicking here

Thank you to IPSEN for their support of this poster session. Visit the IPSEN sponsor page by clicking here

Join us for the closing of the 2021 Conference including the announcement of the Inaugural Helen Crowe Poster Award & the Chris McPherson Nursing Scholarship.

We look forward to welcoming you to Melbourne from the 1 - 3 September, 2022 for the 23rd Asia-Pacific Prostate Cancer Conference. 

PSMA PET has rapidly altered our understanding of the biology of prostate cancer since its introduction just over 5 years ago. Australia has been at the forefront of the PSMA PET revolution, but international experience has rapidly caught up with the publication of several key studies that form the basis for this important session. Local and international speakers will update us on the current state of play and how to best utilize PSMA PET imaging in both early and advanced metastatic disease.

This session is sponsored by Janssen. Chat to the team in the catering breaks by clicking here